can compounded semaglutide still be sold Hims & Hers stock falls 25% as FDA curtails GLP-1s The complicated world of compounded

These can vary widely from person to person

44,45 In a meta-analysis of 48 RCTs including 27,729 participants, the overall incidence of GI adverse events was reported to be 11.6%, with nausea identified as the most common symptom (21.4%)

Today, smaller compounding pharmacies are known as 503As, named after the section of the Federal Food, Drug, and Cosmetic Act that addresses them, and theyre regulated largely by states

While numerous proof-of-concept candidate molecules have been disclosed ( and Zepbound ) ( ex vivo finding, the GIPR monoagonist LY3537021 reduced body weight by ~4.1% over 8 weeks in patients with T2D (n = 18) ( 2.2 GIPR agonism serves to reduce GLP-1R mediated GI AEs in the clinic Treatment with GLP-1R agonists can drive nausea, diarrhea, vomiting, and constipation, which often results in discontinuation of treatment (6-10% of patients) or reduction in dose (~15% of patients) ( It has been hypothesized that the deleterious, nauseating effects of GLP-1R agonists and the beneficial, food-intake reducing effects are inextricably linked

Store in a cool, dry place, protected from light and heat

If switching delivery methods is not possible, discuss with your provider about timing your oral HRT and GLP-1 injections to minimize overlap